CerebraAI is a digital health venture founded in 2018 focused on developing AI-powered software for early stroke diagnosis. Their solution leverages artificial intelligence and cloud technology to analyze non-contrast CT scans, aiming to provide faster and more accurate treatment decisions for healthcare professionals. Targeting hospitals and physicians, the platform operates on a B2B model and has received regulatory approvals in Kazakhstan and is pursuing FDA Breakthrough Device Designation in the US. With partnerships from institutions like Stanford and Nvidia, CerebraAI aims to revolutionize emergency medicine by integrating essential AI solutions into critical care workflows to improve patient outcomes during stroke events.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2020
- Website
- cerebraai.ai/
Categories
Disease Areas
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of CEREBRA?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now